November 2004

  

"ISPOR e-BULLETIN" provides updates of recent ISPOR activities and events. For detailed information on ISPOR activities, members are encouraged to go to www.ispor.org.

 

Please pass these updates along to your colleagues.

  eBulletin Index

 

NEW THIS MONTH

**NEW**    ISPOR CONNECTIONS, Vol. 10 No. 5 September/October 2004

**NEW**    7TH ANNUAL EUROPEAN CONGRESS PHOTO GALLERY

**NEW**    PATIENT REGISTRY SIG SURVEY & RETROSPECTIVE DATABASE SIG

 

**NEW**    ISPOR SEVENTH ANNUAL EUROPEAN CONGRESS CONTRIBUTED PAPER AWARDS RECIPIENTS

**NEW**    LAUNCH OF ISPOR EUROPEAN STUDENT CHAPTER

**NEW**    13 NEW POSITIONS AT ISPOR EMPLOYMENT WEBSITE

**NEW**    ISPOR BOARD OF DIRECTORS CALL FOR NOMINATIONS

**NEW**    ISPOR AWARDS CALL FOR NOMINATIONS

 

ISPOR ONGOING ACTIVITIES

 

1.       Publications

2.       Meetings and Congresses

3.       Educational Activities

4.       Student News

5.       ISPOR Special Interest Groups

6.       Committee and Task Force Activities

7.       Hot Topics

8.       Important Dates to Remember

9.       Employment in Pharmacoeconomics and Outcomes Research

10.    Membership

 


  1. PUBLICATIONS

Top

 

VALUE IN HEALTH

 

Value in Health: Volume 7, Issue 5, September/October 2004 is online and available this month: http://www.ispor.org/valueinhealth_index.asp. 

 

Value in Health: Volume 7, September 2004 Special Issue is online and available this month: http://www.ispor.org/valueinhealth_index.asp. 

 

Value in Health: Volume 7, Issue 6, November/December 2004, which includes the 7th Annual European Congress abstracts, is online and available this month at: http://www.ispor.org/valueinhealth_index.asp.

 

 ISPOR CONNECTIONS

 

ISPOR CONNECTIONS: Volume 10, Issue 5, September/October 2004 is available online to the public at: http://www.ispor.org/news/index_new.asp.  In this issue:

 

Use and Misuse of the Case-Control Methodology in Economic Analyses

J. Jaime Caro, 1Caro Research Institute, Concord, MA, USA; and Krista F. Huybrechts, McGill University, Montreal, Quebec, Canada

 

The Continuing Evolution of Patient Registries: Designing Programs to Meet Broad
Organizational Objectives

Leanne Larson, Ovation Research Group, Highland Park, IL, USA and Peter Malamis, Synthesis, Springfield, VA, USA

 

Issues in the Use of Patient Reported Outcomes in Medical Device Trials: A Report on the “ISPOR Medical Device Forum: Patient Reported Outcomes (PROs) in Device Evaluation: Scientific and Regulatory Challenges”, May 18, 2004, Arlington, VA, USA

Nancy Kline Leidy, PhD, MEDTAP International, Bethesda, MD, USA

 

President’s Fireside Chat

Lieven Annemans, MSc, PhD, 2004-2005 ISPOR President

 

Let’s Get Talking…New Initiatives to Facilitate Communication Among ISPOR Researchers

Elinor Chumney, PhD, Chair of the MC_PBM Research Network Working Group and Assistant Professor, Medical University of South Carolina, Charleston, SC, USA

 

ISPOR Avedis Donabedian Outcomes Research Lifetime Achievement Awardee:
Michael F. Drummond PhD

 

 

HEALTH CARE COST, QUALITY, AND OUTCOMES: ISPOR BOOK OF TERMS  

 

This ISPOR publication includes more than 100 detailed monographs covering over 400 terms used in health care delivery, management, and regulation, as well as health care outcomes research including clinical, economic, and quality-of-life research terms. ISPOR member discounted price is $36.00; a 40% discount!  Student/Library/Academic discounted price: $33.00 (a 45% discount). On-line ordering is now available at: http://www.ispor.org/publications/lexicon_index.asp.  Contact Stephen Priori at spriori@ispor.org for information on orders over 1000. 

 


  

  1. ISPOR MEETINGS AND CONGRESSES

Top

   

10TH ANNUAL INTERNATIONAL MEETING

May 15-18, 2005, Marriott Wardman Park Hotel, Washington, DC, USA

 

CALL FOR ABSTRACTS AVAILABLE ONLINE

SUBMIT YOUR ABSTRACT NOW!

Abstract Deadline: 10 January 2005

Early Registration Deadline: 19 April 2005

 

MEETING AT A GLANCE

http://www.ispor.org/meetings/washington0505/index.asp

 

Sign up for Exhibit Space, contract available online a

 

Sponsorship Opportunities still available, for more information go to

 

7TH ANNUAL EUROPEAN CONGRESS

24-26 October 2004, CCH Congress Centrum Hamburg, Hamburg, Germany

Photo Gallery **NEW**

http://www.ispor.org/congresses/germany1004/photogallery/pages/default.asp

 


 

  1. EDUCATION ACTIVITIES

Top

           

ISPOR SHORT COURSES

-prior to the ISPOR 10TH Annual International Meeting

 

**For short course descriptions and instructor information please go to:

 

Saturday, May 14th: http://www.ispor.org/meetings/washington0505/sc14.asp

Sunday, May 15th: http://www.ispor.org/meetings/washington0505/sc15.asp

 

SATURDAY, MAY 14, 2005

Pharmacoeconomics
Pharmacoeconomics for Decision-makers - Full Day Course (8:00am-5:00pm)

 

Clinical Assessment
Retrospective Database Analysis: Data sources and Methods - Full Day Course (8:00am-5:00pm)

 

Modeling
Bayesian Analysis: Overview - Morning Course (8:00am-12:00pm)

 

Modeling
Bayesian Analysis: Applications - Afternoon Course (1:00pm-5:00pm)

 

Quality of Life/Patient-reported Outcomes
Introduction to Quality of Life/Patient-Reported Outcomes - Afternoon Course (1:00pm-5:00pm)

 

Economic Analysis-
Financial Impact / Cost of Illness - Afternoon Course (1:00pm-5:00pm)

 

SUNDAY , MAY 15, 2005

Modeling
Modeling: Structure & Design of Model -
Full Day Course (8:00am-5:00pm)

 

Pharmacoeconomics
Elements of Pharmaceutical Pricing - Morning Courses (8:00am-12:00pm)

 

Economic Analysis 
Cost Estimation: Finding and Extracting Cost Data - Morning Courses (8:00am-12:00pm)

 

Quality of Life / Patient-reported Outcomes
Old and New Utility Measures in Health Economics and Outcomes Research - Morning Courses (8:00am-12:00pm)

 

Clinical Assessment
Meta-Analysis and Systematic Literature Review - Morning Courses (8:00am-12:00pm)

 

Economic Analysis
Statistical Considerations In Economic Evaluations - Afternoon Courses (1:00pm-5:00pm)

 

Quality of Life/Patient-reported Outcomes
Advanced Quantitative Methods for Quality of Life/Patient-reported Outcomes Research
- Afternoon Courses (1:00pm-5:00pm)

 

Decision Analysis
Introduction to Decision Analysis
- Afternoon Courses (1:00pm-5:00pm)

 

 

ISPOR Distance Learning Program at the ISPOR website:  ISPOR Distance Learning Program

 

The following module topics are available:

 

Pharmacoeconomics

Pharmacoeconomic Evaluations & Methods

Cost-Effectiveness Analysis

Cost-Benefit Analysis

Cost-Utility Analysis

Humanistic Outcomes (Utilities, Health-related Quality of Life, Patient-reported Outcomes, Patient Preferences)

Study Design in Pharmacoeconomics

Guidelines and Reference Standards

 


 

  1. STUDENT NEWS

Top 

**NEW** LAUNCH OF ISPOR EUROPEAN STUDENT CHAPTER

The launch of the ISPOR European Student Chapter (ESC) during the Student Forum at the ISPOR 7th Annual European Congress in Hamburg, Germany was a great success. Special thanks to Larry Humble, Student Network chair, and Zeba Khan, Student Network Advisor, for all their hard work.

For more details on the ISPOR Student Network, please visit: http://www.ispor.org/student/student_index.asp

          


 

 

  1. ISPOR SPECIAL INTEREST GROUPS (SIG)

Top

 

PATIENT REGISTRY SIG

**NEW** Let us know what you think… in less than 5 minutes!  
Participate the Patient Registry SIG Survey!
The Patient Registry SIG is conducting this brief survey to gain a better understanding of the needs of users of patient registry information.  The results will enable the SIG and the Working Groups to focus specifically on activities that will have the greatest benefit to the outcomes research community and users of outcomes research information derived from patient registries.   

 

For survey link and more details, please visit: http://www.ispor.org/sigs/patient_registr.asp

RETROSPECTIVE DATABASE SIG
**NEW** Chairs, Mission, Goals & Working Groups

Co-Chairs:

Michael Johnson PhD, Houston Center for Quality of Care and Utilization Studies, Michael E. DeBakey VA Medical Center, Assistant Professor of Medicine, Baylor College of Medicine
William D. Marder PhD, Senior Vice President & General Manager, Medstat

MISSION: To provide an international forum for ISPOR membership to identify and address comprehensive issues in the development and use of retrospective clinical, survey and administrative databases for pharmacoeconomic outcomes research.
GOALS:  Identify main issues, including determining standards, best practices or gaps that exist in identified areas.   Form workgroups to address the state of the art in each area, producing peer reviewed literature, dissemination of standards and policy recommendations as feasible and appropriate.
WORKING GROUPS: 
Classification of Databases - who, what, where of US, Canadian, European, International clinical, survey, and administrative healthcare databases 
Policy Advocacy
- how research using these sources of information can inform policy decision-making.  
Research Design & Analysis – collect state of the art and future directions on issues of research design and statistical analysis. 
Database Development – represent researcher needs in discussion with public and private database developers as they address data release and other policy concerns. 
Privacy Regulations - impact of HIPAA and other levels of regulation on current and future practice.  

For more details on this SIG, please visit: http://www.ispor.org/sigs/retrospective_db.asp

 

MEDICATION COMPLIANCE SIG

Forum at the 7th European Congress:
Issues in Medication Compliance and Persistence Research:
The forum examined major applied research issues important for the assessment of medication compliance/adherence/persistence. The discussion reviewed the definitions, methods of analyses, economic impact, and educational components currently under development by the SIG. Panelists discussed the approaches with comments and suggestions to help move ISPOR into the forefront of medication analyses and enhancements. 

             For more details on this SIG, please visit: http://www.ispor.org/sigs/medication.asp

 

QUALITY OF LIFE SIG

Forum at the 7th European Congress: Industry and Regulatory Perspectives on Translating Patient Reported Outcome (PRO) measures
The forum compared and contrasted different approaches to translation and cultural validation of instruments prior to their use in clinical trials.  Speakers discussed the potential costs and benefits of these approaches, including their implications for bias and precision of results; and provided regulatory perspectives on issues such as the role of certification and validation requirements for multinational trials.

            For more details on this SIG, please visit: http://www.ispor.org/sigs/qol.asp

HEALTH TECHNOLOGY ASSESSMENT SIG

 

For more details on this SIG, please visit http://www.ispor.org/sigs/hta.asp

 

RISK MANAGEMENT SIG

 

For more details on this SIG, please visit: http://www.ispor.org/sigs/rm.asp

   
MANAGED
CARE_PBM SIG

 

For more details, please visit http://www.ispor.org/sigs/sigsindex.asp

 

CLINICAL PRACTICE SIG

 

For more details, please visit: http://www.ispor.org/sigs/sigsindex.asp

 

Special Interest Group membership is open to ALL ISPOR members.

To JOIN any SIG: http://www.ispor.org/sigs/joinsig.htm

 


 

 

  1. ISPOR BOARD, COMMITTEE, AND TASK FORCE ACTIVITIES

Top

 

            **NEW**ISPOR 2005-2006 BOARD OF DIRECTORS CALL FOR NOMINATIONS

ISPOR is a member-driven organization.  As a member-driven organization, its governance is determined by the membership.  The ISPOR Nominations Committee is seeking qualified candidates for the position of PRESIDENT-ELECT and 2 DIRECTOR positions.

 

You, as an ISPOR member, are invited to submit your name if you wish to be considered for a position on the ISPOR BOARD OF DIRECTORS.  You may also recommend the name of another ISPOR member.  Please email your interest or recommendation to: nominations@ispor.org.

 

Please attach a curriculum vitae.  The deadline for submitting nominations is Monday, February 2, 2005.

 

      AWARD COMMITTEE ACTIVITIES

 

**NEW** ISPOR SEVENTH ANNUAL EUROPEAN CONGRESS CONTRIBUTED PAPER AWARDS RECIPIENTS

 

BEST CONTRIBUTED PAPER AWARDS PODIUM PRESENTATIONS

GENERAL


CV1
A HEALTH ECONOMIC EVALUATION OF ASPIRIN IN THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE

Lamotte M1, Annemans L1, Evers T2, Kubin M3
1HEDM, Meise, Belgium; 2Bayer Vital GmbH, Leverkusen, Germany; 3Bayer HealthCare, Wuppertal, Elberfeld, Germany 

CV3
NURSING HOME RESIDENTS WITH STROKE: CHANGES IN MANAGEMENT LEVELS AND COSTS OVER A SIX YEAR PERIOD

O'Brien JA, Duran P, Caro JJ
Caro Research Institute, Concord, MA, USA 


DB3
DECREASED RATES OF MAJOR HYPOGLYCAEMIC EVENTS LEAD TO IMPROVED LONG TERM COST EFFECTIVENESS OF BIPHASIC INSULIN ASPART 30/70 VERSUS BIPHASIC HUMAN INSULIN 30 IN TYPE 2 DIABETIC SUBJECTS IN DANISH, FINNISH, GERMAN, NORWEGIAN, SPANISH, SWEDISH, AND UK SETTINGS

Lammert M1, Palmer AJ2, Roze S2, Minshall ME3, Valentine WJ2
1Novo Nordisk A/S, Bagsvaerd, Denmark; 2CORE Center for Outcomes Research, Binningen/Basel, Switzerland; 3CORE-USA, Fishers, IN, USA 

NEW INVESTIGATOR


HP4
DRUG COSTS DEVELOPMENT AFTER PATENT EXPIRY IN THE NETHERLANDS

Boersma C, Bos JM, Klok RM, Postma MJ
Groningen University Institute for Drug Exploration / University of Groningen Research Institute of Pharmacy (GUIDE/GRIP), Groningen, Groningen, The Netherlands 

QL7 
VALIDATION OF A PATIENT-ADMINISTERED QUESTIONNAIRE TO MEASURE THE SEVERITY OF LOWER URINARY TRACT SYMPTOMS IN UNCOMPLICATED URINARY TRACT INFECTION: THE UTI SYMPTOM ASSESSMENT (USA) QUESTIONNAIRE
Clayson DJ
1, Wild DJ1, Keating K2, Gondek K2
1Oxford Outcomes Ltd, Oxford, Oxon, UK; 2Bayer HealthCare Pharmaceuticals, West Haven, CT, USA 

UC4
VARIATION IN ADL FUNCTIONING WITHIN BARTHEL INDEX SCORES:IMPLICATIONS FOR STROKE CLINICAL TRIALS AND PRACTICE

Banks JL1, Netten A2, Pollok J3, Van de Peer L3, Salas M4
1Health Outcomes Strategy Group, Boston, MA, USA; 2University of Kent at Canterbury, Canterbury, UK; 3Kent and Canterbury Hospital, Canterbury, UK; 4Erasmus University Medical School, Rotterdam, The Netherlands 

STUDENT


HP3
PHARMACOECONOMIC EDUCATION AT NON-US COLLEGES OF PHARMACY

Nwokeji ED, Rascati K
The University of Texas at Austin, Austin, TX, USA 


BEST CONTRIBUTED PAPER AWARDS POSTER PRESENTATIONS

GENERAL


PCN42
POOLING CLINICAL AND COST OUTCOMES: A CASE STUDY OF BEST SUPPORTIVE CARE (BSC) IN ADVANCED NON SMALL CELL LUNG CANCER (NSCLC)

McAllister R1, Meddis D2, Jansen J1, Ryan J1, Brown J2
1MAPI Values Ltd, Bollington, Cheshire, UK; 2AstraZeneca, Macclesfield, Cheshire, UK

PCV27
COST-EFFECTIVENESS OF BUPROPION IN SMOKING CESSATION IN FINLAND

Hahl J, Jormanainen V
GlaxoSmithKline Oy, Espoo, Finland

PES18
INTERPRETATION OF SCORES ON THE PSORIASIS INDEX OF QOL (PSORIQOL)

McKenna SP1, Meads DM1, Backhouse ME2
1Galen Research, Manchester, UK; 2Novartis Pharma AG, Basel, Switzerland 

NEW INVESTIGATOR

PCN38
THE IMPACT OF SCREENING ADHERENCE ON MEDICAL EFFECTIVENESS AND COST-EFFECTIVENESS OF CERVICAL CANCER SCREENING IN GERMANY – A DECISION ANALYSIS

Sroczynski G1, Voigt K2, Gibis B3, Aidelsburger P4, Engel J5, Wasem J4, Hillemanns P5, Hölzel D5, Goldie SJ6, Siebert U1
1Harvard Medical School, Boston, MA, USA; 2Institute for Medical Informatics, Biostatistics, and Epidemiology, University of Munich, Munich, Germany; 3National Association of Statutory Health Insurance Physicians, Berlin, Germany; 4 University of Duisburg-Essen, Duisburg-Essen, Germany; 5 University of Munich, Munich, Germany; 6 Harvard School of Public Health, Boston, USA

PIN7
COST MINIMIZATION ANALYSIS OF ORAL VALGANCICLOVIR VS. INTRAVENOUS AND ORAL GANCICLOVIR IN THE PREVENTION OF CYTOMEGALOVIRUS INFECTION AND DISEASE IN SOLID ORGAN TRANSPLANT RECIPIENTS

Rubio M1, Oppenheimer F2, Magaz S1, Badia X1
1Health Outcomes Research Europe, Barcelona, Barcelona, Spain; 2Hospital Clinic I Provincial de Barcelona, Barcelona, Spain

PIN10
COST-EFFECTIVENESS OF EXPANDED HIV SCREENING OF BLOOD DONATIONS IN GHANA

Van Hulst M1, Vermande J2, Sagoe K3, Bos JM4, Postma MJ2
1University of Groningen / Martini Hospital, Groningen, Groningen, Netherlands; 2University of Groningen, Groningen, Groningen, Netherlands; 3University of Ghana Medical School, Accra, Accra, Ghana; 4The Netherlands Vaccine Institute, Bilthoven, Utrecht, Netherlands

STUDENT

PCV47
DECISION ANALYSIS ON EFFECTIVENESS AND COST-EFFECTIVENESS OF DISEASE MANAGEMENT PROGRAMS FOR THE TREATMENT OF HEART FAILURE

Goehler A1, Dietz R1, Osterziel KJ1, Siebert U2
1Charitè Campus Virchow Klinikum, Berlin, Germany; 2Harvard Medical School, Boston, MA, USA

PCV63
OVER-ADHERENCE WITH ANTIHYPERTENSIVE MEDICATIONS AMONG CENTRAL TEXAS VETERANS

Yang M, Vincze G, Barner JC
The University of Texas at Austin, Austin, TX, USA

PIN8
ECONOMIC EVALUATION OF HIV TREATMENTS: THE I.CO.N.A. COHORT STUDY

Merito M1, Baio G2, Bonaccorsi A3, Pammolli F4, Riccaboni M4, Arici C5, D’Arminio Monforte A6, Pezzotti P7, Corsini D8
1Sant’Anna School of Advanced Studies, Pisa, PI, Italy; 2University of Florence, Florence, Italy, Italy; 3Sant’Anna School of Advanced Studies, Italy; 4University of Florence, Italy; 5Ospedali Riuniti – Bergamo, Italy; 6University of Milan, Italy; 7Istituto Superiore di Sanità, Italy; 8Informa srl, Italy

 

**NEW** ISPOR RESEARCH EXCELLENCE AWARDS CALL FOR NOMINATIONS

 

The ISPOR Awards Committee is seeking nominees for both the ISPOR Research Excellence Award for Methodology Excellence and Research Excellence Award for Practical Application Excellence.

 

See http://www.ispor.org/awards/methodology_.asp and http://www.ispor.org/awards/application_.asp for Excellence Awards descriptions, criteria, selection process, nature of award, and past recipients.

 

**NEW** ISPOR BERNIE O’BRIEN NEW INVESTIGATOR AWARDS CALL FOR NOMINATIONS

 

The ISPOR Bernie O’Brien New Investigator Award was established in 2004 to honor the long-standing commitment of Bernie J. O’Brien, PhD to training and mentoring new scientists in the fields of outcomes research and pharmacoeconomics. The award will be presented for the first time at the ISPOR 10th Annual International Meeting in Washington, DC, 15-18, 2005.

 

The ISPOR Awards Committee is seeking nominees for this award. See http://www.ispor.org/awards/Obrien_investigator.asp for descriptions, criteria, selection process, and nature of the award.

 

      The deadline to submit nominees for both awards is FEBRUARY 15, 2005.

 

 

HEALTH SCIENCE INITIATIVE: RCT-CEA TASK FORCE

 

The ISPOR 7th Annual European Congress hosted a final RCT-CEA forum on Tuesday, October 26, 2004 The forum consisted of a slide presentation presented by Co-chairs: Scott Ramsey, MD, PhD, Associate Member, Fred Hutchinson Cancer Research Center and Richard Willke, PhD Senior Director, Group Leader, Global Outcome Research, Pfizer, Inc..  After the presentation there was a question and answer period presided over by the two co-chairs and Task Force Core Group members: Andrew Briggs, Dphil, University of Oxford, Health Economics Research Centre, Institute of Health Sciences; Ruth Brown, MS, Director, MEDTAP Int’l, and Martin Buxton, PhD, Professor, Brunel University, Health Economics Research Group.  The forum was attended by approximately 120 Congress attendees.  The final draft document will be sent to all reference group members by mid-November and they will be given an opportunity to comment.  The Final document will be published in the July-August 2005 Value in Health, Volume 8, Issue 4.


  1. HOT TOPICS

Top

 

MEDICARE LAUNCHES EFFORTS TO IMPROVE CARE FOR CANCER PATIENTS

NEW COVERAGE, BETTER EVIDENCE, AND NEW SUPPORT FOR IMPROVING QUALITY OF CARE

 

WASHINGTON, D.C. – (November 1, 2004) – The Centers for Medicare & Medicaid Services (CMS) today announced a set of new steps to improve care for cancer patients by expanding coverage for screening tests and treatments, developing better evidence on which treatments work best for beneficiaries with cancer, and implementing a demonstration program to measure and improve quality of care.

 

For full text of the article, go to: http://www.cms.hhs.gov/media/press/release.asp?Counter=1244

 


 

  1. IMPORTANT DATES TO REMEMBER

Top

 

January 10, 2005 - Abstract Submission deadline for the ISPOR 10th Annual International Meeting.

 

February 2, 2005 Submission deadline for nominees for ISPOR 2005-2006 Board of Directors positions.

 

February 15, 2005 – Submission deadline for nominees for ISPOR Research Excellence Awards and Bernie J. O’Brien  New Investigator Award.

 

April 19, 2005 – Early Meeting registration and hotel reservation deadline for the ISPOR 10th Annual International Meeting, Marriott Wardman Park Hotel, Washington, DC.

 

May 15-18 2005 ISPOR 10th Annual International Meeting, Marriott Wardman Park Hotel, Washington, DC.

 

June 20, 2005 Abstract Submission deadline for the ISPOR 8th Annual European Congress.


  1. EMPLOYMENT

Top

**NEW** 13 NEW POSITIONS AT THE ISPOR WEBSITE Careers

 

            Advertise your positions on ISPOR Website (1 million hits per month)

 


  1. ISPOR MEMBERSHIP

Top

Update your email address at https://www.ispor.org/members/MemberProfile.aspx! Your email address is required as part of your log in information in the members only section of the ISPOR website.

 

 

 


eBulletin Index